Argenx
ARGX
#534
Rank
C$54.80 B
Marketcap
$896.30
Share price
-0.35%
Change (1 day)
90.53%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total assets

Total assets on the balance sheet as of June 2024 : C$6.89 Billion

According to Argenx 's latest financial reports the company's total assets are C$6.89 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Argenx - Total assets on balance sheet (from 2021 to 2020)

Total assets by year

Year Total assets Change
2022-12-31C$4.25 B17.08%
2021-12-31C$3.63 B1.61%
2020-12-31C$3.57 B51.74%
2019-12-31C$2.35 B128.47%
2018-12-31C$1.03 B53.62%
2017-12-31C$0.67 B326.9%
2016-12-31C$0.15 B106.31%
2015-12-31C$76.21 M-24.1%
2014-12-31C$0.10 B97.77%
2013-12-31C$50.77 M68.35%
2012-12-31C$30.16 M-28.52%
2011-12-31C$42.19 M158.82%
2010-12-31C$16.3 M